These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20868268)

  • 41. A comprehensive review of occupational and general population cancer risk: 1,3-Butadiene exposure-response modeling for all leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, myeloid neoplasm and lymphoid neoplasm.
    Sielken RL; Valdez-Flores C
    Chem Biol Interact; 2015 Nov; 241():50-8. PubMed ID: 26070419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The ex vivo L-CBMN assay detects significant human exposure to butadiene.
    Bolognesi C; Kirsch-Volders M
    Mutat Res Rev Mutat Res; 2016; 770(Pt A):73-83. PubMed ID: 27894692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leukemia and exposure to 1,3-butadiene, styrene and dimethyldithiocarbamate among workers in the synthetic rubber industry.
    Delzell E; Macaluso M; Sathiakumar N; Matthews R
    Chem Biol Interact; 2001 Jun; 135-136():515-34. PubMed ID: 11397410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation on the mechanisms of genotoxicity of butadiene, styrene and their combination in human lymphocytes using the Comet assay.
    Cemeli E; Mirkova E; Chiuchiarelli G; Alexandrova E; Anderson D
    Mutat Res; 2009 May; 664(1-2):69-76. PubMed ID: 19428383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative human health risk assessment for 1,3-butadiene based upon ovarian effects in rodents.
    Kirman CR; Grant RL
    Regul Toxicol Pharmacol; 2012 Mar; 62(2):371-84. PubMed ID: 22100993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 1,3-Butadiene, styrene and lymphohematopoietic cancer among male synthetic rubber industry workers--Preliminary exposure-response analyses.
    Sathiakumar N; Brill I; Leader M; Delzell E
    Chem Biol Interact; 2015 Nov; 241():40-9. PubMed ID: 26343807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary metabolites and haemoglobin adducts as biomarkers of exposure to 1,3-butadiene: a basis for 1,3-butadiene cancer risk assessment.
    Boogaard PJ; van Sittert NJ; Megens HJ
    Chem Biol Interact; 2001 Jun; 135-136():695-701. PubMed ID: 11397424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of risk assessments on 1,3-butadiene (1985-1991).
    Cagen SZ; MacDonald RL; Van Gelder G
    Toxicology; 1996 Oct; 113(1-3):215-20. PubMed ID: 8901900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of the potential risk to workers from exposure to 1,3-butadiene.
    Turnbull D; Rodricks JV; Brett SM
    Environ Health Perspect; 1990 Jun; 86():159-71. PubMed ID: 2205486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative toxicity of dithiocarbamates and butadiene metabolites in human lymphoid and bone marrow cells.
    Irons RD; Stillman WS; Pyatt DW; Yang Y; Le A; Gustafson DL; Hua Zheng J
    Chem Biol Interact; 2001 Jun; 135-136():615-25. PubMed ID: 11397416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanistic data indicate that 1,3-butadiene is a human carcinogen.
    Melnick RL; Kohn MC
    Carcinogenesis; 1995 Feb; 16(2):157-63. PubMed ID: 7859343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A preliminary regional PBPK model of lung metabolism for improving species dependent descriptions of 1,3-butadiene and its metabolites.
    Campbell J; Van Landingham C; Crowell S; Gentry R; Kaden D; Fiebelkorn S; Loccisano A; Clewell H
    Chem Biol Interact; 2015 Aug; 238():102-10. PubMed ID: 26079054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Butadiene: species comparison for metabolism and genetic toxicology.
    Anderson D
    Mutat Res; 1998 Sep; 405(2):247-58. PubMed ID: 9748609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dithiocarbamates as potential confounders in butadiene epidemiology.
    Irons RD; Pyatt DW
    Carcinogenesis; 1998 Apr; 19(4):539-42. PubMed ID: 9600335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health risk assessment of 1,3-butadiene as a Priority Substance in Canada.
    Hughes K; Meek ME; Walker M
    Chem Biol Interact; 2001 Jun; 135-136():109-35. PubMed ID: 11397385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An updated lymphohematopoietic and bladder cancers risk evaluation for occupational and environmental exposures to 1,3-butadiene.
    Valdez-Flores C; Erraguntla N; Budinsky R; Cagen S; Kirman CR
    Chem Biol Interact; 2022 Oct; 366():110077. PubMed ID: 36029806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex-specific differences in genotoxic and epigenetic effects of 1,3-butadiene among mouse tissues.
    Lewis L; Chappell GA; Kobets T; O'Brian BE; Sangaraju D; Kosyk O; Bodnar W; Tretyakova NY; Pogribny IP; Rusyn I
    Arch Toxicol; 2019 Mar; 93(3):791-800. PubMed ID: 30552462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industry--Part II: Carcinogenicity, mutagenicity, and developmental toxicity of 1,3-butadiene.
    Mehlman MA; Legator MS
    Toxicol Ind Health; 1991 May; 7(3):207-20. PubMed ID: 1949058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human cancer risk and exposure to 1,3-butadiene--a tale of mice and men.
    Stayner LT; Dankovic DA; Smith RJ; Gilbert SJ; Bailer AJ
    Scand J Work Environ Health; 2000 Aug; 26(4):322-30. PubMed ID: 10994798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of co-exposure to dimethyldithiocarbamate on butadiene metabolism.
    Green T; Toghill A; Moore R
    Chem Biol Interact; 2001 Jun; 135-136():585-98. PubMed ID: 11397414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.